Omega Fund Management  Inc. logo

Omega Fund Management Inc. Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Omega Fund Management Inc. with $222.4M in long positions as of Q3 2025, 82% allocated to Unknown, and 100% concentrated in top 10 positions.

Portfolio Value
$222.4M
Top 10 Concentration
100%
Top Sector
Unknown (82%)
US Exposure
98%
Market Cap Focus
Small Cap
Countries
2

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 18.20%Healthcare
Healthcare
18.20%

Industry Breakdown

1 industry across all sectors

Biotechnology: 18.16%Biotechnology
Biotechnology
Healthcare
18.16%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Small Cap ($300M - $2B): 98.30%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 1.67%N/A (ETF or Unknown): 0.03%
Small Cap ($300M - $2B)
98.30%
Micro Cap ($50M - $300M)
1.67%
N/A (ETF or Unknown)
0.03%

Portfolio Concentration

Top 10 Holdings %
99.5%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
98.35%
International
1.65%
Countries
2
Largest Int'l Market
Canada - 1.65%
United States of America
98.35% ($218.7M)
10 holdings
Canada
1.65% ($3.7M)
2 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
6 quarters
Avg. Top 20
7.9 quarters
Avg. All Positions
7.9 quarters
Median Holding Period
4.5 quarters
Persistence Rate
58.33%
Persistent Holdings Weight
34.98%
Persistent Positions
7
Longest Held
Replimune Group, Inc. logo
Replimune Group, Inc.REPL - 28 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
17.13%
Avg. Position Weight
8.33%
Largest Position
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS - 17.59%
Largest Ownership Stake
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX - 4.42%
Avg. Ownership Stake
3.43%
Ownership Stake >5%
0
Ownership Stake >1%
8

Historical (Since Q4 2014)

Avg. New Position
16.53%
Avg. Ownership Stake
6.29%
Largest Position
FibroGen, Inc logo
FibroGen, IncFGEN - 100.00% (Q4 2014)
Largest Ownership Stake
Nuvation Bio Inc. logo
Nuvation Bio Inc.NUVB - 12.95% (Q2 2021)

Portfolio Turnover

Current Quarter

Turnover Ratio
19.9%
Value Traded
$44.23M
Positions Added
1
Positions Exited
2

Historical (Since Q4 2014)

Avg. Turnover Ratio
12.9%
Avg. Positions Added
1
Avg. Positions Exited
1
Highest Turnover
50.0%
Q4 2014

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.